Forward Look

Treatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.

by Isobel Whitcomb

Could changes spurred by safety concerns during the pandemic make clinical trials more accessible to patients?

by Charlotte Huff

Facts and Stats

While there are many kinds of lung cancer, screening recommendations are standard across the board.

by Bradley Jones

9/11 first responders' cancer survival compares favorably to the general population, and a study identifies different mutational signatures in lung cancers from never-smokers

by Marci A. Landsmann

A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.

by Pamela Rafalow Grossman

Regular exercise can help mitigate cognitive problems associated with chemotherapy, and researchers learn more about the link between cholesterol and cancer.

by Bradley Jones

Patient volume at radiation therapy clinics can affect outcomes, and experts call attention to a third breast cancer gene, PALB2.

by Marci A. Landsmann

Survival is not affected by delaying breast cancer treatment for fertility preservation, and the FDA approves a drug combination to treat kidney cancer.

by Kevin McLaughlin

People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

by Pamela Rafalow Grossman

Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.

by Marci A. Landsmann